{
  "id": "bc7840d201d3bfaa",
  "title": "Bioxytran Conference : CEO touts broad - spectrum antiviral strategy , cites strong COVID Phase II results",
  "description": "20260210T080000Z",
  "content": "",
  "source": "tickerreport.com",
  "source_url": "https://www.tickerreport.com/banking-finance/13341351/bioxytran-conference-ceo-touts-broad-spectrum-antiviral-strategy-cites-strong-covid-phase-ii-results.html",
  "published_at": "20260210T080000Z",
  "fetched_at": "2026-02-11T00:34:18.892628+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.tickerreport.com/banking-finance/13341351/bioxytran-conference-ceo-touts-broad-spectrum-antiviral-strategy-cites-strong-covid-phase-ii-results.html",
    "url_mobile": "",
    "title": "Bioxytran Conference : CEO touts broad - spectrum antiviral strategy , cites strong COVID Phase II results",
    "seendate": "20260210T080000Z",
    "socialimage": "",
    "domain": "tickerreport.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}